The insider sales are routine post-earnings cashless option exercises by the CEO and a small CFO sale, the dollar amounts are trivial relative to market cap and carry no bearish signal. Monitor for any 10b5-1 plan disclosures or additional insider sales in the next 30 days, but this cluster alone does not warrant action. The more material event is the volixibat pipeline delay from the Aug 5 earnings release.
MIRM drugs
MIRM drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Aug 13 $98.77entry
- T+1 · 3mo ago +1.89%α +2.09% · $100.64
- T+5 · 3mo ago −1.61%α +0.35% · $97.18
- T+20 · 2mo ago −0.56%α +1.19% · $98.22
- T+60 · 11d ago −5.11%α +0.36% · $93.72
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Mirum Pharmaceuticals CEO Christopher Peetz and CFO Eric Bjerkholt sold a combined $1.75M in open-market stock within two days of the company's Q2 2026 earnings release, which showed strong 38% revenue growth but a significant GAAP EPS miss (-$1.06 vs -$0.75 consensus) and a key pipeline delay for volixibat. The CEO's sales ($1.98M total, including derivative exercises) and CFO's sale ($600K) represent ~0.03% of the $6.4B market cap, a trivial proportion that is likely liquidity-driven following option exercises rather than a bearish signal. The cluster is a net sell but the dollar amount is immaterial relative to company size, and the CEO's derivative exercise and same-day sale is a classic cashless exercise pattern, not an informed sell signal.
Key Financial Metrics
Key Facts
- CEO Peetz sold 20,000 shares via derivative exercise and open-market sales totaling ~$1.98M on Aug 10
- CFO Bjerkholt sold 6,001 shares for ~$600K on Aug 11
- Total cluster open-market sales: ~$2.55M (including CEO's derivative exercise cost of $58,720)
- Sales represent ~0.04% of MIRM's $6.4B market cap, well below the 0.1% materiality threshold
- Cluster occurred 5-6 days after Q2 earnings (Aug 5) which showed 38% revenue growth but a GAAP EPS miss and volixibat delay
- CEO's trades include a same-day derivative exercise and sale, consistent with a cashless stock option exercise pattern
Financial Impact
Total open-market sales of ~$2.55M represent ~0.04% of market cap, immaterial
Risk Factors
- Pipeline setback for volixibat (NDA delayed to H1 2027 after FDA recommended Phase 3 study)
- GAAP EPS miss (-$1.06 vs -$0.75 consensus) driven by heavy R&D/SG&A spending
- CEO and CFO both selling post-earnings could be perceived negatively by retail investors despite trivial size
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-MIRM-1786608259408 |
Track record
27 reports on MIRM
5 of 5 bullish or bearish reports moved the stock their way by T+60. Best: +28.29% at T+20 after the Jun 11, 2026 report. 8 of 10 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $92.28 Now $91.58 −0.76% settles Feb 12
- Nov 13, 20263d ago Insider Cluster Neutral 3/10 Entry $93.54 Now $91.58 −2.10% settles Feb 12
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $93.33 Now $91.58 −1.88% settles Feb 10
- Nov 10, 20266d ago 8-K Bullish 6/10 Entry $94.42 Now $91.58 −3.01% settles Feb 8
- Nov 4, 202612d ago 144 Neutral 2/10 Entry $93.54 Now $91.58 −2.10% settles Feb 3
- Nov 4, 202612d ago 144 Neutral 2/10 Entry $93.54 Now $91.58 −2.10% settles Feb 3
- Nov 3, 202613d ago 8-K Bullish 6/10 Entry $96.97 Now $91.58 −5.56% settles Feb 2
- Oct 27, 202620d ago Institutional Cluster Mixed 4/10 Entry $85.81 Now $91.58 +6.72% settles Jan 26
- Oct 26, 202621d ago 8-K Bullish 6/10 Entry $85.56 Now $91.58 +7.04% settles Jan 25
- Oct 13, 20264w ago 8-K Bullish 7/10 Entry $79.62 Now $91.58 +15.02% settles Jan 8
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers